NANOX IMAGING LTD
Sector: Healthcare & Life Sciences
About NANOX IMAGING LTD
Nanox (Nasdaq: NNOX) is a leader in digital X-ray technology. In February 2026, the company received FDA 510(k) clearance for 'TAP2D,' a cloud-enabled image enhancement feature that generates 2D views from 3D scans, moving the Nanox.ARC closer to being a standalone primary diagnostic solution in the US.
Products
Nanox.ARC:
Medical imaging. Enhances anatomy visualization and reduces the super-imposition of structures.Affordable, advanced digital multi-source 3D tomosynthesis imaging system Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. Provides a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach. The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provides access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
Latest Company Updates
- Activating Latent Data to Promote Early Detection:The Role of AI in CT Imaging
- Nanox highlights at ECR 2026 Vienna
- Nanox Showcases End-to-End Medical Imaging Innovations and AI Solutions at ECR to Improve Patient Access and Outcomes
- A virtual trial evaluation of patient motion in arc and linear system designs in body digital tomosynthesis
- FFN Webinar What AI Can Do for FLS. Professor Kassim Javaid details how AI can scale Fracture Liaison Services by automating fracture detection and patient data summarization.